Market Overview

US Stock Futures Flat Ahead Of Economic Data

Related FB
#PreMarket Primer: Monday, July 28: Tension Between U.S. And Israel On The Rise
Weekly Highlights: Apple's iTime Patent, Amazon's Fire Phone Suppliers And More
Tech Rewind: Amazon Slides, Facebook Goes Mobile (Fox Business)
Related LEN
3 Homebuilder Stocks To Watch Ahead of Earnings
Barclays Revises Price Targets On Homebuilders
Construction Jobs Hit Five-Year High (Fox Business)

Pre-open movers

US stock futures traded mostly flat in early pre-market trade, ahead of economic data. The FHFA house price index and the S&P/Case-Shiller home price index for July will be released at 9:00 a.m. ET. The Conference Board's consumer confidence index and the Richmond Fed manufacturing index for September will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average gained 4 points to 15,330.00, while the Standard & Poor's 500 index futures fell 0.50 points to 1,692.20. Futures for the Nasdaq 100 index rose 5 points to 3,214.00.

A Peek Into Global Markets

European markets were mostly higher today, with the Spanish Ibex Index rising 0.32%, London's FTSE 100 index gaining 0.10% and STOXX Europe 600 Index climbing 0.10%. German DAX 30 index rose 0.11% and French CAC 40 Index surged 0.52%.

Asian markets ended mostly lower today. Japan's Nikkei Stock Average fell 0.07%, China's Shanghai Composite declined 0.61% and Australia's ASX/S&P500 dropped 0.31%. Hong Kong's Hang Seng index fell 0.82% and India's Sensex gained 0.10%.

Broker Recommendation

Analysts at Citigroup upgraded Facebook (NASDAQ: FB) from “neutral” to “buy.” The target price for Facebook has been raised from $32 to $55. Facebook's shares gained 1.63% to $47.96 in pre-market trading.

Breaking news

  • Lennar (NYSE: LEN) reported a 39% rise in its third-quarter net profit. Lennar's quarterly net profit surged to $120.7 million, or $0.54 per share, from $87.1 million, or $0.40 per share, in the year-ago period. To read the full news, click here.
  • Sanofi (NYSE: SNY) announced today new GetGoal-L sub-analysis results showing that reductions in HbA1c with Lyxumia® (lixisenatide), when added to basal insulin, were greatest in patients with type 2 diabetes who had well-controlled baseline fasting plasma glucose (FPG). To read the full news, click here.
  • ICF International (NASDAQ: ICFI) has been awarded a re-compete contract with the U.S. Environmental Protection Agency (EPA) for Homeland Security Presidential Directive 12 (HSPD-12) and Identity, Credential, and Access Management (ICAM) support. To read the full news, click here.
  • National Oilwell Varco (NYSE: NOV) announced today that its Board of Directors has authorized Company management to move forward with exploration of a plan to spin-off NOV's distribution business from the remainder of the Company, creating two stand-alone, publicly traded corporations. To read the full news, click here.

Posted-In: Citigroup US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

 

Most Popular

Related Articles (ICFI + FB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters